CD44 and prostate carcinoma: For example, some membrane markers, including CD44, CD133, CD24, and α2β1 integrin, are used successfully by these methods to isolate prostate cancer stem-like cells (PCSCs) or tumor progenitor cells from cell lines and primary tumors [19–21].